Cetirizine Withdrawn in US Over Mix-up

Doses of Cetirizine Hydrochloride tablets have been withdrawn in the United States due to potential contamination with traces of Ranitidine (Zantac), a medication used to reduce stomach acid. The company has not received any reports of related health issues but has advised consumers to stop using the affected tablets. Recall procedures have begun in collaboration with the distributor. The FDA warns that the contamination could cause severe allergic reactions, especially in individuals allergic to Ranitidine, which may lead to serious symptoms such as low blood pressure, difficulty breathing, and swelling. In critical cases, it could result in severe respiratory complications. The reason for the recall is accidental contamination that occurred during manufacturing due to the use of the same production equipment for different products, with some of the affected tablets showing signs of contamination in the form of red spots and discoloration.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل